Clinical trial
Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153…
NCT00365105 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00365105 |
|---|---|
| Title | Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer |
| Official title | Randomized Phase III Trial to Evaluate Radiopharmaceuticals and Zoledronic Acid in the Palliation of Osteoblastic Metastases From Lung, Breast, and Prostate Cancer |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH NRG Oncology |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer, Lung Cancer, Metastatic Cancer, Pain, Prostate Cancer |
| Intervention type | Dietary Supplement, Drug, Radiation |
| Interventions | Calcium, Vitamin D, zoledronic acid, Sm-153, Sr-89 |
| Enrollment | 261 |
| Start date | Jul 11, 2006 |
| Primary completion | Jan 1, 2012 |
| Completion | Feb 27, 2017 |
| First posted | Aug 17, 2006 |
| Last update posted | Sep 20, 2024 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: